Vanda Pharmaceuticals buy StockNews.com
Start price
04.03.23
/
50%
€5.90
Target price
04.03.24
-
Performance (%)
-34.24%
End price
05.03.24
€3.88
Summary
This prediction ended on 05.03.24 with a price of €3.88. Massive losses of -34.24% were the result for the BUY prediction by StockNews_com. StockNews_com has a follow-up prediction for Vanda Pharmaceuticals where he still thinks Vanda Pharmaceuticals is a Buy. StockNews_com has 50% into this predictionPerformance without dividends (%)
Name | 1w | 1m | 1y |
---|---|---|---|
Vanda Pharmaceuticals | -10.000% | -10.000% | -24.211% |
iShares Core DAX® | 2.594% | -1.158% | 14.782% |
iShares Nasdaq 100 | 3.553% | -1.727% | 43.265% |
iShares Nikkei 225® | 0.687% | -8.354% | 18.454% |
iShares S&P 500 | 2.209% | -0.942% | 31.361% |
Comments by StockNews_com for this prediction
In the thread Vanda Pharmaceuticals diskutieren
Vanda Pharmaceuticals Inc. (NASDAQ: VNDA) was upgraded by analysts at StockNews.com from a "buy" rating to a "strong-buy" rating.
Ratings data for VNDA provided by MarketBeat
In the thread Trading Vanda Pharmaceuticals
Die von StockNews_com gewählte maximale Laufzeit wurde überschritten